Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer

Stamm, H; Oliveira-Ferrer, L; Grossjohann, EM; Muschhammer, J; Thaden, V; Brauneck, F; Kischel, R; Muller, V; Bokemeyer, C; Fiedler, W; Wellbrock, J

Wellbrock, J (reprint author), Hubertus Wald Univ, Univ Med Ctr Hamburg Eppendorf, Sect Pneumol, Dept Oncol Hematol & Bone Marrow Transplantat,Can, Hamburg, Germany.

ONCOIMMUNOLOGY, 2019; 8 (12):

Abstract

Immune checkpoints are intensively investigated as targets in cancer therapy. T-cell immunoreceptor with immunoglobulin (Ig) and ITIM domains (TIGIT) ......

Full Text Link